Xanthomas of Tendon - Causes, Treatment & When to See a Doctor

```html

What is Xanthomas of Tendon?

Xanthomas of tendon, also called tendon xanthomas, are firm, yellow‑orange nodules that develop within tendons, most commonly the Achilles tendon, extensor tendons of the hands, and the patellar tendon. They represent collections of lipid‑laden macrophages (foam cells) that infiltrate the connective tissue of the tendon. While they are usually painless, their presence is a visual clue that underlying lipid metabolism is abnormal, most often familial hypercholesterolemia (FH). Recognizing tendon xanthomas early can prompt life‑saving interventions to lower cardiovascular risk.

Common Causes

Several metabolic, genetic, and systemic conditions can lead to the formation of tendon xanthomas. The most frequent c etiologies include:

• Familial hypercholesterolemia (FH) – type IIA: An autosomal‑dominant disorder caused by mutations in the LDL‑receptor, APOB, or PCSK9 genes. This is the classic setting for tendon xanthomas.
• Familial combined hyperlipidemia: Elevated LDL‑cholesterol and triglycerides increase foam‑cell formation.
• Familial dysbetalipoproteinemia (type III hyperlipoproteinemia): Presence of ApoE2/E2 genotype leads to remnant accumulation.
• Secondary hyperlipidemia due to uncontrolled diabetes mellitus, hypothyroidism, or nephrotic syndrome.
• Cholesterol‑depositing skin disorders such as xanthelasma palpebrarum (often seen together with tendon xanthomas).
• Hepatic cholestasis (e.g., primary biliary cholangitis) where impaired bile flow raises serum cholesterol.
• Medications that raise lipids – e.g., corticosteroids, cyclosporine, certain antiretroviral drugs.
• Rare lysosomal storage diseases (e.g., Niemann‑Pick disease type C) that cause lipid accumulation.
• Acquired lipid disorders after organ transplantation due to immunosuppressive regimens.
• Inborn errors of metabolism such as sitosterolemia, where plant sterols accumulate.

Associated Symptoms

Because tendon xanthomas themselves are usually non‑painful, they are often discovered incidentally or when a patient notices a lump. However, they frequently coexist with other signs of lipid disorders:

• Yellow plaques on eyelids (xanthelasma)
• Yellowish papules on the hands, elbows, or knees (tuberous or plane xanthomas)
• Family history of early‑onset coronary artery disease or sudden cardiac death
• Chest pain or angina, especially if atherosclerosis has progressed
• Peripheral vascular symptoms (claudication, cold extremities)
• Fatigue, shortness of breath, or reduced exercise tolerance related to cardiovascular disease
• In rare cases, tendon rupture due to weakening of the tendon by lipid infiltration

When to See a Doctor

Prompt evaluation is recommended if you notice any of the following:

• Firm, yellow‑orange nodules on a tendon that gradually enlarge
• Sudden increase in size or tenderness of a known nodule
• History of high cholesterol, especially if diagnosed before age 30
• Family members with premature heart attacks or known FH
• Chest discomfort, shortness of breath, or atypical pain radiating to the arm/jaw
• Symptoms of peripheral artery disease (pain while walking, cold feet)

Even if the nodules are asymptomatic, seeing a clinician is critical because they signal an elevated risk for heart disease, which may be silent until a serious event occurs.

Diagnosis

Evaluation of tendon xanthomas involves a combination of clinical examination, imaging, and laboratory testing.

1. Clinical Examination

• Careful inspection and palpation of the Achilles, extensor tendons of the hands, and patellar tendon.
• Documentation of size, number, and location of lesions.
• Assessment for other cutaneous xanthomas and signs of hyperlipidemia.

2. Laboratory Studies

• Lipid panel – total cholesterol, LDL‑C, HDL‑C, triglycerides.
• Genetic testing for FH mutations (LDLR, APOB, PCSK9) when the phenotype is suggestive.
• Secondary causes: fasting glucose/HbA1c, thyroid‑stimulating hormone (TSH), liver function tests, urine protein.

3. Imaging

• Ultrasound – non‑invasive, shows hyperechoic thickening of the tendon consistent with xanthoma.
• Magnetic Resonance Imaging (MRI) – detailed view, helps differentiate from tendon rupture or tumors.
• Computed Tomography (CT) Calcium Score – evaluates concurrent coronary artery calcification, useful for risk stratification.

4. Histopathology (rare)

In atypical cases where malignancy cannot be ruled out, a biopsy may be performed. Microscopy reveals sheets of foam cells filled with lipid vacuoles.

Treatment Options

Treatment is two‑fold: addressing the visible xanthomas and, more importantly, correcting the underlying lipid disorder to prevent cardiovascular complications.

1. Lipid‑Lowering Therapy

• Statins (e.g., atorvastatin, rosuvastatin) – first‑line agents that lower LDL‑C by 30‑50%.
• Ezetimibe – added when LDL‑C remains >100 mg/dL on maximally tolerated statin.
• PCSK9 inhibitors (evolocumab, alirocumab) – especially effective in FH; can reduce LDL‑C >60%.
• Bile‑acid sequestrants – colesevelam, cholestyramine, useful as adjuncts.
• Lipoprotein apheresis – considered for refractory homozygous FH or severe heterozygous FH with progressive disease.

Goal LDL‑C: < 70 mg/dL for very high‑risk patients, < 100 mg/dL for high‑risk according to ACC/AHA guidelines.<sup>1</sup>

2. Lifestyle Modifications

• Diet: Emphasize plant sterol‑fortified foods, soluble fiber, nuts, fatty fish; limit saturated fat, trans‑fat, and dietary cholesterol.
• Physical activity: ≥150 minutes of moderate‑intensity aerobic exercise per week.
• Weight management: Achieve BMI < 25 kg/m² when possible.
• Smoking cessation – one of the strongest modifiers of cardiovascular risk.

3. Direct Management of the Nodules

• Observation: In many patients, xanthomas shrink slowly after lipid levels are well controlled.
• Surgical excision: Considered when nodules cause functional limitation, pain, or cosmetic concern. Recurrence is possible if lipid levels remain high.
• Laser therapy or cryotherapy: Small skin‑surface lesions may be treated, but deeper tendon lesions are less responsive.

4. Monitoring and Follow‑up

• Lipid panel every 3–6 months until target reached, then annually.
• Cardiovascular imaging (stress test, coronary CT, carotid ultrasound) guided by risk.
• Periodic reassessment of tendon lesions for size change.

Prevention Tips

Because tendon xanthomas are a manifestation of systemic lipid imbalance, primary prevention centers on maintaining healthy cholesterol levels throughout life.

• Know your numbers: Obtain a fasting lipid panel at least every 5 years after age 20, or earlier if risk factors exist.
• Family screening: If a first‑degree relative has FH or premature heart disease, have your lipids checked and discuss genetic testing.
• Heart‑healthy diet from childhood: Encourage fruits, vegetables, whole grains, and lean proteins.
• Regular physical activity for all ages.
• Control secondary causes: Keep diabetes, hypothyroidism, and kidney disease well managed.
• Avoid tobacco and excessive alcohol – both worsen lipid profiles.
• Medication adherence: Take prescribed lipid‑lowering drugs exactly as directed; never stop without consulting your clinician.

Emergency Warning Signs

If you experience any of the following, seek emergency medical care (call 911 or go to the nearest emergency department):

• Sudden, severe chest pain or pressure lasting >5 minutes, especially with shortness of breath, sweating, or nausea – possible heart attack.
• New, rapid onset of weakness, numbness, or facial droop – could signal stroke.
• Severe, sudden swelling or pain in a limb accompanied by discoloration – may indicate acute arterial occlusion.
• Rapidly enlarging, painful tendon mass that interferes with walking or hand function – consider tendon rupture or infection.

---

References:

1. American College of Cardiology/American Heart Association. 2022 Guideline on the Management of Blood Cholesterol. Circulation. 2022;145:e285–e350.
2. Mayo Clinic. Tendon xanthoma. mayoclinic.org
3. National Institute of Health – Genetics Home Reference. Familial hypercholesterolemia. ghr.nlm.nih.gov
4. Cleveland Clinic. How to treat xanthomas. my.clevelandclinic.org
5. World Health Organization. WHO Guidelines on Lipid Management. 2021.

```